These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription. El-Tanani M; Platt-Higgins A; Rudland PS; Campbell FC J Biol Chem; 2004 May; 279(20):20794-806. PubMed ID: 14990565 [TBL] [Abstract][Full Text] [Related]
4. Wnt-β-catenin-Tcf-4 signalling-modulated invasiveness is dependent on osteopontin expression in breast cancer. Ravindranath A; Yuen HF; Chan KK; Grills C; Fennell DA; Lappin TR; El-Tanani M Br J Cancer; 2011 Aug; 105(4):542-51. PubMed ID: 21772333 [TBL] [Abstract][Full Text] [Related]
5. Cancer-associated stroma reveals prognostic biomarkers and novel insights into the tumour microenvironment of colorectal cancer and colorectal liver metastases. Brown KM; Xue A; Smith RC; Samra JS; Gill AJ; Hugh TJ Cancer Med; 2022 Jan; 11(2):492-506. PubMed ID: 34874125 [TBL] [Abstract][Full Text] [Related]
6. Osteopontin-enhanced hepatic metastasis of colorectal cancer cells. Huang J; Pan C; Hu H; Zheng S; Ding L PLoS One; 2012; 7(10):e47901. PubMed ID: 23112867 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer. Likui W; Hong W; Shuwen Z J Gastrointest Surg; 2010 Jan; 14(1):74-81. PubMed ID: 19763701 [TBL] [Abstract][Full Text] [Related]
8. Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells. Wai PY; Mi Z; Gao C; Guo H; Marroquin C; Kuo PC J Biol Chem; 2006 Jul; 281(28):18973-82. PubMed ID: 16670084 [TBL] [Abstract][Full Text] [Related]
9. Relationship between osteopontin and β-catenin immunohistochemical expression and prognostic parameters of colorectal carcinoma. Youssef NS; Osman WM Int J Clin Exp Pathol; 2015; 8(2):1503-14. PubMed ID: 25973035 [TBL] [Abstract][Full Text] [Related]
10. Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma. Mesci A; Taeb S; Huang X; Jairath R; Sivaloganathan D; Liu SK World J Gastroenterol; 2014 Dec; 20(46):17376-87. PubMed ID: 25516649 [TBL] [Abstract][Full Text] [Related]
11. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells. Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031 [TBL] [Abstract][Full Text] [Related]
12. In vitro and clinical data analysis of Osteopontin as a prognostic indicator in colorectal cancer. Wei R; Wong JPC; Lyu P; Xi X; Tong O; Zhang SD; Yuen HF; Shirasawa S; Kwok HF J Cell Mol Med; 2018 Sep; 22(9):4097-4105. PubMed ID: 29851214 [TBL] [Abstract][Full Text] [Related]
13. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma. Zhao J; Lu B; Xu H; Tong X; Wu G; Zhang X; Liang A; Cong W; Dai J; Wang H; Wu M; Guo Y Hepatology; 2008 Jul; 48(1):265-75. PubMed ID: 18537194 [TBL] [Abstract][Full Text] [Related]
14. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer. Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of beta-catenin in colorectal cancer with liver metastasis. Han SA; Chun H; Park CM; Kang SJ; Kim SH; Sohn D; Yun SH; Lee WY Clin Oncol (R Coll Radiol); 2006 Dec; 18(10):761-7. PubMed ID: 17168211 [TBL] [Abstract][Full Text] [Related]
16. Targeting circ-0034880-enriched tumor extracellular vesicles to impede SPP1 Zhou J; Song Q; Li H; Han Y; Pu Y; Li L; Rong W; Liu X; Wang Z; Sun J; Song Y; Hu X; Zhu G; Zhu H; Yang L; Ge G; Li H; Ji Q Mol Cancer; 2024 Aug; 23(1):168. PubMed ID: 39164758 [TBL] [Abstract][Full Text] [Related]
17. Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker. Lin AY; Chua MS; Choi YL; Yeh W; Kim YH; Azzi R; Adams GA; Sainani K; van de Rijn M; So SK; Pollack JR PLoS One; 2011 Feb; 6(2):e16636. PubMed ID: 21383983 [TBL] [Abstract][Full Text] [Related]
18. USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4. Li Y; Yang Y; Li J; Liu H; Chen F; Li B; Cui B; Liu Y Oncotarget; 2017 May; 8(20):32683-32695. PubMed ID: 28427243 [TBL] [Abstract][Full Text] [Related]